Table of Contents Global Immune Check Point Inhibitor Market Research Report 2023, Forecast to 2028 1 Market Study Overview 1.1 Study Objectives 1.2 Immune Check Point Inhibitor Introduce 1.3 Combined with the Analysis of Macroeconomic Indicators 1.4 Brief Description of Research methods 1.5 Market Breakdown and Data Triangulation 2 Global Trend Summary 2.1 Immune Check Point Inhibitor Segment by Type 2.1.1 CLTA-4 Inhibitors 2.1.2 PD-1 & PD-L1 Inhibitor 2.2 Market Analysis by Application 2.2.1 Lung Cancer 2.2.2 Blood Cancer 2.2.3 Renal Cancer 2.2.4 Bladder Cancer 2.2.5 Melanoma 2.2.6 Hodgkin Lymphoma 2.3 Global Immune Check Point Inhibitor Market Comparison by Regions (2018-2028) 2.3.1 Global Immune Check Point Inhibitor Market Size (2018-2028) 2.3.2 North America Immune Check Point Inhibitor Status and Prospect (2018-2028) 2.3.3 Europe Immune Check Point Inhibitor Status and Prospect (2018-2028) 2.3.4 China Immune Check Point Inhibitor Status and Prospect (2018-2028) 2.3.5 Japan Immune Check Point Inhibitor Status and Prospect (2018-2028) 2.3.6 Southeast Asia Immune Check Point Inhibitor Status and Prospect (2018-2028) 2.4 Basic Product Information 2.4.1 Basic Product Information & Technology Development History 2.4.2 Product Manufacturing Process 2.4.3 Interview with Major Market Participants 2.4.4 High-end Market Analysis and Forecast 2.5 Coronavirus Disease 2020 (Covid-19): Immune Check Point Inhibitor Industry Impact 2.5.1 Immune Check Point Inhibitor Business Impact Assessment - Covid-19 2.5.2 Market Trends and Immune Check Point Inhibitor Potential Opportunities in the COVID-19 Landscape 2.5.3 Measures / Proposal against Covid-19 3 Competition by Manufacturer 3.1 Global Immune Check Point Inhibitor Sales and Market Share by Manufacturer (2018-2023) 3.2 Global Immune Check Point Inhibitor Revenue and Market Share by Manufacturer (2018-2023) 3.3 Global Immune Check Point Inhibitor Industry Concentration Ratio (CR5 and HHI) 3.4 Top 5 Immune Check Point Inhibitor Manufacturer Market Share 3.5 Top 10 Immune Check Point Inhibitor Manufacturer Market Share 3.6 Date of Key Manufacturers Enter into Immune Check Point Inhibitor Market 3.7 Key Manufacturers Immune Check Point Inhibitor Key Manufacturers 3.8 Mergers & Acquisitions Planning 4 Analysis of Immune Check Point Inhibitor Industry Key Manufacturers 4.1 Bristol-Myers Squibb Company 4.1.1 Compan Detail 4.1.2 Bristol-Myers Squibb Company Immune Check Point Inhibitor Product Introduction, Application and Specification 4.1.3 Bristol-Myers Squibb Company 130 Sales, Price, Cost, Gross Margin, and Revenue (2018-2023) 4.1.4 Main Business Overview 4.1.5 Bristol-Myers Squibb Company News 4.2 AstraZeneca plc 4.2.1 Compan Detail 4.2.2 AstraZeneca plc Immune Check Point Inhibitor Product Introduction, Application and Specification 4.2.3 AstraZeneca plc Immune Check Point Inhibitor Sales, Price, Cost, Gross Margin, and Revenue (2018-2023) 4.2.4 Main Business Overview 4.2.5 Bristol-Myers Squibb Company News 4.3 Merck & Co 4.3.1 Compan Detail 4.3.2 Merck & Co Immune Check Point Inhibitor Product Introduction, Application and Specification 4.3.3 Merck & Co Immune Check Point Inhibitor Sales, Price, Cost, Gross Margin, and Revenue (2018-2023) 4.3.4 Main Business Overview 4.3.5 Merck & Co News 4.4 Pfizer, Inc 4.4.1 Compan Detail 4.4.2 Pfizer, Inc Immune Check Point Inhibitor Product Introduction, Application and Specification 4.4.3 Pfizer, Inc Immune Check Point Inhibitor Sales, Price, Cost, Gross Margin, and Revenue (2018-2023) 4.4.4 Main Business Overview 4.4.5 Pfizer, Inc News 4.5 F. Hoffmann-La Roche Ltd 4.5.1 Compan Detail 4.5.2 Pfizer, Inc Immune Check Point Inhibitor Product Introduction, Application and Specification 4.5.3 F. Hoffmann-La Roche Ltd Immune Check Point Inhibitor Sales, Price, Cost, Gross Margin, and Revenue (2018-2023) 4.5.4 Main Business Overview 4.5.5 F. Hoffmann-La Roche Ltd News 4.6 Incyte Corporation 4.6.1 Compan Detail 4.6.2 Incyte Corporation Immune Check Point Inhibitor Product Introduction, Application and Specification 4.6.3 Incyte Corporation Immune Check Point Inhibitor Sales, Price, Cost, Gross Margin, and Revenue (2018-2023) 4.6.4 Main Business Overview 4.6.5 Incyte Corporation News 4.7 NewLink Genetics Corporation 4.7.1 Compan Detail 4.7.2 NewLink Genetics Corporation Immune Check Point Inhibitor Product Introduction, Application and Specification 4.7.3 NewLink Genetics Corporation Immune Check Point Inhibitor Sales, Price, Cost, Gross Margin, and Revenue (2018-2023) 4.7.4 Main Business Overview 4.7.4 Main Business Overview 4.8 Celldex Therapeutics, Inc 4.8.1 Compan Detail 4.8.2 Celldex Therapeutics, Inc Immune Check Point Inhibitor Product Introduction, Application and Specification 4.8.3 Celldex Therapeutics, Inc Immune Check Point Inhibitor Sales, Price, Cost, Gross Margin, and Revenue (2018-2023) 4.8.4 Main Business Overview 4.8.5 Celldex Therapeutics, Inc News 4.9 GlaxoSmithKline plc 4.9.1 Compan Detail 4.9.2 GlaxoSmithKline plc Immune Check Point Inhibitor Product Introduction, Application and Specification 4.9.3 GlaxoSmithKline plc Immune Check Point Inhibitor Sales, Price, Cost, Gross Margin, and Revenue (2018-2023) 4.9.4 Main Business Overview 4.9.5 GlaxoSmithKline plc News 4.10 Seattle Genetics, Inc. 4.10.1 Compan Detail 4.10.2 Seattle Genetics, Inc. Immune Check Point Inhibitor Product Introduction, Application and Specification 4.10.3 Seattle Genetics, Inc. Immune Check Point Inhibitor Sales, Price, Cost, Gross Margin, and Revenue (2018-2023) 4.10.4 Main Business Overview 4.10.5 Seattle Genetics, Inc. News 5 Global Immune Check Point Inhibitor Market Segment by Big Type 5.1 Global Immune Check Point Inhibitor Revenue, Sales and Market Share by Big Type (2018-2023) 5.1.1 Global Immune Check Point Inhibitor Sales and Market Share by Big Type (2018-2023) 5.1.2 Global Immune Check Point Inhibitor Revenue and Market Share by Big Type (2018-2023) 5.2 CLTA-4 Inhibitors Sales Growth Rate and Price 5.2.1 Global CLTA-4 Inhibitors Sales Growth Rate (2018-2023) 5.2.2 Global CLTA-4 Inhibitors Price (2018-2023) 5.3 PD-1 & PD-L1 Inhibitor Sales Growth Rate and Price 5.3.1 Global PD-1 & PD-L1 Inhibitor Sales Growth Rate (2018-2023) 5.3.2 Global PD-1 & PD-L1 Inhibitor Price (2018-2023) 6 Global Immune Check Point Inhibitor Market Segment by Big Application 6.1 Global Immune Check Point Inhibitor Sales Market Share by Big Application (2018-2023) 6.2 Lung Cancer Sales Growth Rate (2018-2023) 6.3 Blood Cancer Sales Growth Rate (2018-2023) 6.4 Renal Cancer Sales Growth Rate (2018-2023) 6.5 Bladder Cancer Sales Growth Rate (2018-2023) 6.6 Melanoma Sales Growth Rate (2018-2023) 6.7 Hodgkin Lymphoma Sales Growth Rate (2018-2023) 7 Global Immune Check Point Inhibitor Forecast 7.1 Global Immune Check Point Inhibitor Revenue, Sales and Growth Rate (2023-2028) 7.2 Immune Check Point Inhibitor Market Forecast by Regions (2023-2028) 7.2.1 North America Immune Check Point Inhibitor Market Forecast (2023-2028) 7.2.2 Europe Immune Check Point Inhibitor Market Forecast (2023-2028) 7.2.3 China Immune Check Point Inhibitor Market Forecast (2023-2028) 7.2.4 Japan Immune Check Point Inhibitor Market Forecast (2023-2028) 7.2.5 Southeast Asia Immune Check Point Inhibitor Market Forecast (2023-2028) 7.2.6 Other Regions Immune Check Point Inhibitor Market Forecast (2023-2028) 7.3 Immune Check Point Inhibitor Market Forecast by Type (2023-2028) 7.3.1 Global Immune Check Point Inhibitor Sales Forecast by Type (2023-2028) 7.3.2 Global Immune Check Point Inhibitor Market Share Forecast by Type (2023-2028) 7.4 Immune Check Point Inhibitor Market Forecast by Application (2023-2028) 7.4.1 Global Immune Check Point Inhibitor Sales Forecast by Application (2023-2028) 7.4.2 Global Immune Check Point Inhibitor Market Share Forecast by Application (2023-2028) 8 Market Analysis 8.1.1 Market Overview 8.1.2 Market Opportunities 8.1.3 Market Risk 8.1.4 Market Driving Force 8.1.5 Porter's Five Forces Analysis 8.1.6 SWOT Analysis 9 Immune Check Point Inhibitor Related Market Analysis 9.1 Upstream Analysis 9.1.1 Macro Analysis of Upstream Markets 9.1.2 Key Players in Upstream Markets 9.1.3 Upstream Market Trend Analysis 9.1.4 Immune Check Point Inhibitor Manufacturing Cost Analysis 9.2 Downstream Market Analysis 9.2.1 Macro Analysis of Down Markets 9.2.2 Key Players in Down Markets 9.2.3 Downstream Market Trend Analysis 9.2.4 Sales Channel, Distributors, Traders and Dealers 10 Research Findings and Conclusion

List of Tables and Figures Figure Product Picture Immune Check Point Inhibitor Figure Market Concentration Ratio and Market Maturity Analysis of Immune Check Point Inhibitor Figure Bottom-up and Top-down Approaches for This Report Figure Part of Our External Database Figure Part of Our External Database Figure Key Executives Interviewed Table Global Immune Check Point Inhibitor Market Size by Big Type Figure Global Market Share of Immune Check Point Inhibitor by Big Type in 2022 Figure CLTA-4 Inhibitors Picture (2018-2023) Global Immune Check Point Inhibitor Market Size by Big Application Table Global Immune Check Point Inhibitor Market Size by Application Figure Global Immune Check Point Inhibitor Market Share by Big Application in 2022 Figure Lung Cancer Picture Figure Blood Cancer Picture Figure Renal Cancer Picture Figure Bladder Cancer Picture Figure Melanoma Picture Figure Hodgkin Lymphoma Picture Table Global Immune Check Point Inhibitor Comparison by Regions (M USD) （2018-2028） Figure Global Immune Check Point Inhibitor Market Size (Million US$) (2018-2028) Figure North America Immune Check Point Inhibitor Revenue (Million US$) Growth Rate (2018-2028) Figure Europe Immune Check Point Inhibitor Revenue (Million US$) Growth Rate (2018-2028) Figure China Immune Check Point Inhibitor Revenue (Million US$) Growth Rate (2018-2028) Figure Japan Immune Check Point Inhibitor Revenue (Million US$) Growth Rate (2018-2028) Figure Southeast Asia Immune Check Point Inhibitor Revenue (Million US$) Growth Rate (2018-2028) Table Business Impact Assessment - Covid-19 Table Market Trends and Immune Check Point Inhibitor Potential Opportunities in the COVID-19 Landscape Table Measures / Proposal against Covid-19 Table Global Immune Check Point Inhibitor Sales by Manufacturer (2018-2023) Figure Global Immune Check Point Inhibitor Sales Market Share by Manufacturer in 2022 Table Global Immune Check Point Inhibitor Revenue by Manufacturer (2018-2023) Figure Global Immune Check Point Inhibitor Revenue Market Share by Manufacturer in 2022 Table Global Immune Check Point Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Immune Check Point Inhibitor Manufacturer (Revenue) Market Share in 2022 Figure Top 10 Immune Check Point Inhibitor Manufacturer (Revenue) Market Share in 2022 Table Date of Key Manufacturers Enter into Immune Check Point Inhibitor Market Table Key Manufacturers Immune Check Point Inhibitor Product Type Table Mergers & Acquisitions Planning Table Bristol-Myers Squibb Company Company Profile Table Immune Check Point Inhibitor Product Introduction, Application and Specification of Bristol-Myers Squibb Company Table Immune Check Point Inhibitor Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2018-2023 Table Company One Main Business Table Company One Recent Development Table AstraZeneca plc Company Profile Table Immune Check Point Inhibitor Product Introduction, Application and Specification of AstraZeneca plc Table Immune Check Point Inhibitor Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023 Table AstraZeneca plc Recent Development Table Merck & Co Company Profile Table Immune Check Point Inhibitor Product Introduction, Application and Specification of Merck & Co Table Immune Check Point Inhibitor Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023 Table Merck & Co Main Business Table Merck & Co Recent Development Table Pfizer, Inc Company Profile Table Immune Check Point Inhibitor Product Introduction, Application and Specification of Pfizer, Inc Table Immune Check Point Inhibitor Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023 Table Pfizer, Inc Main Business Table Pfizer, Inc Recent Development Table Pfizer, Inc Main Business Table Pfizer, Inc Recent Development Table F. Hoffmann-La Roche Ltd Company Profile Table Immune Check Point Inhibitor Product Introduction, Application and Specification of F. Hoffmann-La Roche Ltd Table Immune Check Point Inhibitor Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023 Table F. Hoffmann-La Roche Ltd Main Business Table F. Hoffmann-La Roche Ltd Recent Development Table Incyte Corporation Company Profile Table Immune Check Point Inhibitor Product Introduction, Application and Specification of Incyte Corporation Table Immune Check Point Inhibitor Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023 Table Incyte Corporation Main Business Table Incyte Corporation Recent Development Table NewLink Genetics Corporation Company Profile Table Immune Check Point Inhibitor Product Introduction, Application and Specification of NewLink Genetics Corporation Table Immune Check Point Inhibitor Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023 Table NewLink Genetics Corporation Main Business Table NewLink Genetics Corporation Recent Development Table Celldex Therapeutics, Inc Company Profile Table Immune Check Point Inhibitor Product Introduction, Application and Specification of Celldex Therapeutics, Inc Table Immune Check Point Inhibitor Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023 Table Celldex Therapeutics, Inc Main Business Table Celldex Therapeutics, Inc Recent Development Table GlaxoSmithKline plc Company Profile Table Immune Check Point Inhibitor Product Introduction, Application and Specification of GlaxoSmithKline plc Table Immune Check Point Inhibitor Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023 Table GlaxoSmithKline plc Main Business Table GlaxoSmithKline plc Recent Development Table Seattle Genetics, Inc. Company Profile Table Immune Check Point Inhibitor Product Introduction, Application and Specification of Seattle Genetics, Inc. Table Immune Check Point Inhibitor Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2018-2023 Table Seattle Genetics, Inc. Main Business Table Seattle Genetics, Inc. Recent Development Figure Global Immune Check Point Inhibitor Sales and Growth Rate (2018-2023) Figure Global Immune Check Point Inhibitor Revenue and Growth Rate (2018-2023) Table Global Immune Check Point Inhibitor Sales by Regions (2018-2023) Figure Global Immune Check Point Inhibitor Sales Market Share by Regions in 2022 Table Global Immune Check Point Inhibitor Revenue by Regions (2018-2023) Figure Global Immune Check Point Inhibitor Revenue Market Share by Regions in 2022 Figure North America Immune Check Point Inhibitor Sales and Growth Rate (2018-2023) Figure Europe Immune Check Point Inhibitor Sales and Growth Rate (2018-2023) Figure China Immune Check Point Inhibitor Sales and Growth Rate (2018-2023) Figure Japan Immune Check Point Inhibitor Sales and Growth Rate (2018-2023) Figure Southeast Asia Immune Check Point Inhibitor Sales and Growth Rate (2018-2023) Figure Other Regions Immune Check Point Inhibitor Sales and Growth Rate (2018-2023) Table Global Immune Check Point Inhibitor Sales by Big Type (2018-2023) Table Global Immune Check Point Inhibitor Sales Market Share by Big Type (2018-2023) Figure Global Immune Check Point Inhibitor Sales Market Share by Big Type in 2020 Table Global Immune Check Point Inhibitor Revenue by Big Type (2018-2023) Table Global Immune Check Point Inhibitor Revenue Market Share by Big Type (2018-2023) Table Global Immune Check Point Inhibitor Revenue Market Share by Big Type in 2020 Figure Global CLTA-4 Inhibitors Sales Growth Rate (2018-2023) Figure Global CLTA-4 Inhibitors Price (2018-2023) Figure Global PD-1 & PD-L1 Inhibitor Sales Growth Rate (2018-2023) Table Global Immune Check Point Inhibitor Sales by Big Application (2018-2023) Table Global Immune Check Point Inhibitor Sales Market Share by Big Application (2018-2023) Figure Global Immune Check Point Inhibitor Sales Market Share by Big Application in 2020 Figure Global Lung Cancer Sales Growth Rate (2018-2023) Figure Global Blood Cancer Sales Growth Rate (2018-2023) Figure Global Renal Cancer Sales Growth Rate (2018-2023) Figure Global Bladder Cancer Sales Growth Rate (2018-2023) Figure Global Melanoma Sales Growth Rate (2018-2023) Figure Global Hodgkin Lymphoma Sales Growth Rate (2018-2023) Figure Global Immune Check Point Inhibitor Sales and Growth Rate (2023-2028) Figure Global Immune Check Point Inhibitor Revenue and Growth Rate (2023-2028) Table Global Immune Check Point Inhibitor Sales Forecast by Regions (2023-2028) Table Global Immune Check Point Inhibitor Market Share Forecast by Regions (2023-2028) Figure North America Sales Immune Check Point Inhibitor Market Forecast (2023-2028) Figure Europe Sales Immune Check Point Inhibitor Market Forecast (2023-2028) Figure China Sales Immune Check Point Inhibitor Market Forecast (2023-2028) Figure Japan Sales Immune Check Point Inhibitor Market Forecast (2023-2028) Figure Southeast Asia Sales Immune Check Point Inhibitor Market Forecast (2023-2028) Figure Other Regions Sales Immune Check Point Inhibitor Market Forecast (2023-2028) Table Global Immune Check Point Inhibitor Sales Forecast by Type (2023-2028) Table Global Immune Check Point Inhibitor Market Share Forecast by Type (2023-2028) Table Global Immune Check Point Inhibitor Sales Forecast by Application (2023-2028) Table Global Immune Check Point Inhibitor Market Share Forecast by Application (2023-2028) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table Macro Analysis of Upstream Markets Table Key Players in Upstream Markets Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Immune Check Point Inhibitor Table Macro Analysis of Down Markets Table Key Players in Down Markets Table Key Players of Downstream Markets Figure Sales Channel Figure North America Immune Check Point Inhibitor Sales (K Units) Growth Rate Forecast (2022-2026) Figure North America Immune Check Point Inhibitor Revenue (Million US$) Growth Rate Forecast (2022-2026) Figure Europe Immune Check Point Inhibitor Sales (K Units) Growth Rate Forecast (2022-2026) Figure Europe Immune Check Point Inhibitor Revenue (Million US$) Growth Rate Forecast (2022-2026) Figure Japan Immune Check Point Inhibitor Production (K Units) Growth Rate Forecast (2022-2026) Figure Japan Immune Check Point Inhibitor Revenue (Million US$) Growth Rate Forecast (2022-2026) Figure China Immune Check Point Inhibitor Production (K Units) Growth Rate Forecast (2022-2026) Figure China Immune Check Point Inhibitor Revenue (Million US$) Growth Rate Forecast (2022-2026) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Bristol-Myers Squibb Company AstraZeneca plc Merck & Co Pfizer, Inc F. Hoffmann-La Roche Ltd Incyte Corporation NewLink Genetics Corporation Celldex Therapeutics, Inc